A significant retrospective study from the Breast Cancer Linkage Consortium revealed an elevated chance of uterine cancer for BRCA1 mutation carriers, but weren’t for BRCA2 mutation carriers (RR = 2.65; 95% CI: [1.69,4.16]; P < 0.001) [10, 36]. The gene discussed is BRCA2; the disease is uterine cancer.